Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU

Phase II study of simultaneous infusion of levozolinate for injection and 5-FU as first-line treatment for advanced colorectal cancer

Trial Details

NCT ID
NCT07391618
Phase
PHASE2
Sponsor
Chinese PLA General Hospital
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • mFOLFOX/FOLFIRI ( Standard Chemotherapy)
Locations (sample)
  • Beijing, China|39.9075,116.39723

Key Eligibility Criteria

  • The subjects voluntarily joined this study and signed the informed consent form.
  • Age: 18 to 75 years old, gender not limited;
  • ECOG PS score: 0-2 points
  • Patients with unresectable or metastatic colorectal cancer confirmed by histology or cytology, where the primary tumor location and the status of R…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →